Dose optimisation of first-line tuberculosis drugs using therapeutic drug monitoring in saliva: feasible for rifampicin, not for isoniazid

被引:8
作者
van den Elsen, Simone H. J. [1 ,2 ,3 ]
Akkerman, Onno W. [4 ,5 ]
Wessels, Mireille [1 ]
Jongedijk, Erwin M. [1 ]
Ghimire, Samiksha [1 ]
van der Werf, Tjip S. [5 ,6 ]
Bolhuis, Mathieu S. [1 ]
Touw, Daan J. [1 ]
Alffenaar, Jan-Willem C. [1 ,7 ,8 ,9 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands
[2] Hosp Grp Twente, Dept Clin Pharm, Almelo, Netherlands
[3] Hosp Grp Twente, Dept Clin Pharm, Hengelo, Netherlands
[4] Univ Groningen, Univ Med Ctr Groningen, TB Ctr Beatrixoord, Haren, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Groningen, Netherlands
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands
[7] Univ Sydney, Sydney Pharm Sch, Fac Med & Hlth, Sydney, NSW, Australia
[8] Westmead Hosp, Sydney, NSW, Australia
[9] Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia
关键词
PHARMACODYNAMICS;
D O I
10.1183/13993003.00803-2020
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:4
相关论文
共 15 条
[1]   Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis [J].
Alffenaar, Jan-Willem C. ;
Gumbo, Tawanda ;
Dooley, Kelly E. ;
Peloquin, Charles A. ;
Mcilleron, Helen ;
Zagorski, Andre ;
Cirillo, Daniela M. ;
Heysell, Scott K. ;
Silva, Denise Rossato ;
Migliori, Giovanni Battista .
CLINICAL INFECTIOUS DISEASES, 2020, 70 (08) :1774-1780
[2]   Simultaneous determination of clarithromycin, rifampicin and their main metabolites in human plasma by liquid chromatography-tandem mass spectrometry [J].
de Velde, Femke ;
Alffenaar, Jan-Willem C. ;
Wessels, A. Mireille A. ;
Greijdanus, Ben ;
Uges, Donald R. A. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2009, 877 (18-19) :1771-1777
[3]  
Ghimire S, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/aac.02379-18, 10.1128/AAC.02379-18]
[4]   Incorporating therapeutic drug monitoring into the World Health Organization hierarchy of tuberculosis diagnostics [J].
Ghimire, Samiksha ;
Bolhuis, Mathieu S. ;
Sturkenboom, Marieke G. G. ;
Akkerman, Onno W. ;
de Lange, Wiel C. M. ;
van der Werf, Tjip S. ;
Alffenaar, Jan-Willem C. .
EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (06) :1867-1869
[5]   Validation of a simple HPLC-UV method for rifampicin determination in plasma: Application to the study of rifampicin arteriovenous concentration gradient [J].
Goutal, Sebastien ;
Auvity, Sylvain ;
Legrand, Tiphaine ;
Hauquier, Fanny ;
Cisternino, Salvatore ;
Chapy, Helene ;
Saba, Wadad ;
Tournier, Nicolas .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2016, 123 :173-178
[6]   Isoniazid bactericidal activity and resistance emergence: Integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations [J].
Gumbo, Tawanda ;
Louie, Arnold ;
Liu, Weiguo ;
Brown, David ;
Ambrose, Paul G. ;
Bhavnani, Sujata M. ;
Drusano, George L. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (07) :2329-2336
[7]   Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis [J].
Jayaram, R ;
Gaonkar, S ;
Kaur, P ;
Suresh, BL ;
Mahesh, BN ;
Jayashree, R ;
Nandi, V ;
Bharat, S ;
Shandil, RK ;
Kantharaj, E ;
Balasubramanian, V .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) :2118-2124
[8]   Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes [J].
Pasipanodya, Jotam G. ;
McIlleron, Helen ;
Burger, Andre ;
Wash, Peter A. ;
Smith, Peter ;
Gumbo, Tawanda .
JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (09) :1464-1473
[9]   Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic Variability [J].
Srivastava, Shashikant ;
Pasipanodya, Jotam G. ;
Meek, Claudia ;
Leff, Richard ;
Gumbo, Tawanda .
JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (12) :1951-1959
[10]  
Sturkenboom MGG., 2015, J APPL BIOANAL, V1, P89, DOI [10.17145/jab.15.015, DOI 10.17145/jab.15.015]